id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-275946-ofd2ipvs	Cheng, Matthew P.	Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review	2020-06-04		.txt	text/plain	5287	182	27	The time course of the immune response to experimental coronavirus infection of man The convalescent sera option for containing COVID-19 Use of convalescent plasma therapy in SARS patients in Hong Kong The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study Effectiveness of convalescent plasma therapy in severe COVID-19 patients Testing an old therapy against a new disease: convalescent plasma for COVID-19 Deployment of convalescent plasma for the prevention and treatment of COVID-19 Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial Subunit vaccines against emerging pathogenic human coronaviruses SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection Prospects for a MERS-CoV spike vaccine A pneumonia outbreak associated with a new coronavirus of probable bat origin Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19) Analysis and interpretation of the data Drafting of the article Administrative, technical, or logistic support: C. Caya. The figure shows a decision tree for interpreting antibody test results by symptomatology (symptomatic, postsymptomatic, asymptomatic or subclinical) and whether the patient is a suspected case.	cache/cord-275946-ofd2ipvs.txt	txt/cord-275946-ofd2ipvs.txt
